NVDA — NVIDIA Corporation

The August 26, 2026 report was a clean beat-and-raise: revenue topped consensus by ~$4.3B, Q3 guidance of $108B was well above the prior model, and management's FY2028 outlook of ~70% growth was a step-change from the Street's ~45%. As of 2026-08-27, the stock is up ~8.7% to $227.98, 60 of 79 covering analysts rate it Buy/Strong Buy, and the consensus 12-month target is $345.21.

Revenue growth is accelerating, not merely elevated: YoY revenue growth stepped from 62.5% (Oct-2025 quarter) to 73.2% (Jan-2026), 85.2% (Apr-2026), and 105.9% (Jul-2026). Operating margin expanded from ~60.8% a year earlier to 66.2%, while gross margin stayed near 75%. The main blemish is cash conversion: Q2 FY2027 operating cash flow was $24.1B vs net income of $59.7B as receivables and inventory ballooned. Q1 net income also included non-operating items, so operating income is the cleanest trend metric.

As of 2026-08-27, the stock is cheap relative to its own 5-year history: TTM P/E of 28.7x is roughly half the 59.7x 5-year average, and TTM P/S of 18.2x is below the 21.8x average. The provided next-FY EPS estimate of $9.02 puts the forward P/E near 25x, and the 0.23 PEG makes it look inexpensive for a company growing revenue 106%. Absolute valuation is still demanding at a $5.52T market cap, but relative to the growth trajectory, it is not rich.

At $227.98, the market is paying roughly 25x this year's earnings estimate while management is pointing to ~70% growth next year. If FY2028 revenue grows 70% and net margin normalizes to ~60%, EPS could be in the mid-to-high teens, making today's share price only ~13-15x FY2028E. That suggests the stock is not fully pricing the guided up-cycle; it also means any stumble in AI capex would trigger outsized multiple compression.

Technicals were constructive as of 2026-08-27: RSI stood at 61.32, strong but not overbought, and price sat above the 20-, 50-, and 200-day SMAs by +4.96%, +9.52%, and +16.48%, respectively. The post-earnings gap created a breakout, but a pullback toward the 20-day SMA would provide a better entry than buying the spike.

• Top U.S. hyperscalers are projected to spend ~$1.3T on AI capex next year, up from prior ~$1.0T forecasts.
• China export controls: Q3 FY2027 guidance embeds zero China data-center compute revenue.
• Memory costs (HBM) are pressuring gross margin to ~74% in Q3, a modest but real headwind.
• With beta of 2.2, NVDA is highly sensitive to interest-rate shifts and risk appetite.
• AI infrastructure remains supply-constrained rather than demand-limited; GPU rental pricing and customer commitments are strong.

• Q3 FY2027 earnings (expected late Nov 2026): must hit or raise the $108B revenue guide and stabilize gross margin near 74%.
• Vera Rubin platform ramp through late 2026/2027, the next major architectural upgrade cycle.
• Continued hyperscaler order disclosures (e.g. AWS multi-million GPU commitments) validating the $1.3T capex pipeline.
• Any easing of export restrictions to China would reopen a large revenue stream.

• AI capex cyclicality: if hyperscalers pause spending, $31.6B inventory and $279B supply commitments could become impairments.
• Customer concentration: a small number of hyperscalers account for the bulk of Data Center revenue and negotiating power.
• Working-capital strain: Q2 operating cash flow was only $24.1B vs $59.7B net income, and receivables/inventory are absorbing huge cash.
• Geopolitical/export-control risk: no China data-center compute revenue in Q3, and further tightening is possible.
• Multiple compression risk: at a $5.52T market cap, any growth shortfall could bring the 28.7x TTM P/E down sharply.

NVDA is the highest-quality AI infrastructure franchise in the market right now: revenue growth is accelerating, margins are elite, and forward guidance understates near-term demand. For a long-term investor comfortable with high volatility and concentration, it is a good but position-sized holding as of 2026-08-27; the main risk is not the business today, but the cyclicality of hyperscaler capex and the cash-conversion drag.

Using the provided next-fiscal-year EPS estimate of $9.02 and a deliberately conservative 35x justified P/E—a big discount to the 59.7x 5-year average P/E but above the 28.7x TTM multiple, reflecting accelerating 100%+ growth and best-in-class margins—gives a standalone fair value of roughly $315.84.